We are live on
!
Find out more
NAM
Needelman Asset Management Portfolio holdings
AUM
$46M
1-Year Est. Return
8.27%
This Fund
S&P 500
This Quarter
Est. Return
+1.82%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$27.4M
AUM Growth
–
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
100.58%
Top 10 Holdings %
Top 10 Hldgs %
34.21%
Holding
38
New
38
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.03M |
| 2 |
Bank of America
BAC
|
+$996K |
| 3 |
Honeywell
HON
|
+$959K |
| 4 |
Procter & Gamble
PG
|
+$954K |
| 5 |
Vodafone
VOD
|
+$923K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.66% |
| 2 | Financials | 17.97% |
| 3 | Technology | 13.59% |
| 4 | Industrials | 11.22% |
| 5 | Consumer Staples | 11.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$618B
| $1.04M | 3.81% |
+12,160
| New | +$1.03M |
|
|
2
Bank of America
BAC
$435B
| $1M | 3.67% |
+78,086
| New | +$996K |
|
|
3
Honeywell
HON
$77B
| $991K | 3.62% |
+13,906
| New | +$959K |
|
4
JPMorgan Chase
JPM
$935B
| $953K | 3.48% |
+18,053
| New | +$918K |
|
|
5
Procter & Gamble
PG
$336B
| $936K | 3.42% |
+12,156
| New | +$954K |
|
6
Berkshire Hathaway Class B
BRK.B
$1.1T
| $909K | 3.32% |
+8,125
| New | +$894K |
|
|
7
Vodafone
VOD
$36.3B
| $907K | 3.31% |
+30,955
| New | +$923K |
|
8
UnitedHealth
UNH
$376B
| $882K | 3.22% |
+13,465
| New | +$838K |
|
9
Yum! Brands
YUM
$41.8B
| $870K | 3.18% |
+17,450
| New | +$864K |
|
10
Intel
INTC
$455B
| $868K | 3.17% |
+35,827
| New | +$846K |
|
11
Diageo
DEO
$49B
| $832K | 3.04% |
+7,239
| New | +$876K |
|
12
Apple
AAPL
$4.54T
| $820K | 3% |
+57,904
| New | +$891K |
|
|
CB
13
DELISTED
CHUBB CORPORATION
CB
| $795K | 2.9% |
+9,395
| New | +$822K |
|
14
Qualcomm
QCOM
$155B
| $792K | 2.89% |
+12,960
| New | +$827K |
|
15
Kimberly-Clark
KMB
$36.3B
| $774K | 2.83% |
+8,316
| New | +$802K |
|
16
Teva Pharmaceuticals
TEVA
$40.8B
| $756K | 2.76% |
+19,280
| New | +$751K |
|
17
Pfizer
PFE
$143B
| $745K | 2.72% |
+28,041
| New | +$775K |
|
18
Fluor
FLR
$7.01B
| $725K | 2.65% |
+12,230
| New | +$743K |
|
19
Chevron
CVX
$392B
| $722K | 2.64% |
+6,100
| New | +$737K |
|
20
Elevance Health
ELV
$81.5B
| $710K | 2.59% |
+8,670
| New | +$649K |
|
21
Verizon
VZ
$195B
| $704K | 2.57% |
+13,982
| New | +$714K |
|
22
Bristol-Myers Squibb
BMY
$133B
| $690K | 2.52% |
+15,430
| New | +$670K |
|
23
Aon
AON
$76.5B
| $689K | 2.52% |
+10,705
| New | +$678K |
|
24
Emerson Electric
EMR
$83.9B
| $684K | 2.5% |
+12,535
| New | +$705K |
|
25
GE Aerospace
GE
$374B
| $671K | 2.45% |
+6,038
| New | +$668K |
|
Similar funds
PRHC
BC
SCPM
SAM
BCP
AVA
GG
SM
Needelman Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Needelman Asset Management, which disclosed 38 positions worth $27.4M. Its ten largest holdings account for 34% of the portfolio.
Its largest position is Johnson & Johnson: 12,160 shares worth $1.04M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Financials and Technology.
- Needelman Asset Management's largest Q2 2013 buy was Johnson & Johnson: 12,160 shares worth $1.04M.
- Needelman Asset Management's ten largest holdings make up 34% of its $27.4M portfolio in Q2 2013.
- Needelman Asset Management disclosed 38 positions in Q2 2013, its first 13F filing on record.
Based on Needelman Asset Management's 13F filing for Q2 2013, filed 25 Jul 2013.